Search - tctmd.com

Displaying 381 - 400 of 564

Sort: Relevancy | Date

Presentation

Proton-Pump Inhibitors (PPIs) Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy

Presenter: Muthia Vaduganathan

March 22, 2016

Presentation

Stopping vs Continuing Aspirin Before Coronary Artery Surgery

Presenter: Paul Myles

February 24, 2016

Presentation Scripps 2016

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

Presenter: Brian Whisenant

February 04, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Rationale and Identifying the Patient Who Might Benefit

Presenter: Brian K. Whisenant

February 03, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Presenter: Brian K. Whisenant

February 03, 2016

Presentation

Efficacy, Safety of Available Protocols for Aspirin Hypersensitivity for Patients Undergoing PCI

Presenter: Matteo Bianco

January 20, 2016

Presentation

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Presenter: G. Qian

December 08, 2015

Presentation

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Presenter: Schjerning Olsen

October 28, 2015

Presentation

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Presenter: R. Khatib

October 26, 2015

Presentation TCT 2015

Neurological Complications of TEVAR: Prevention and Management

Presenter: Wilson Y. Szeto, Rodney White, Michael D. Dake

October 15, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Emerson C. Perin

October 15, 2015

Presentation TCT 2015

Vorapaxar: Lessons From the Randomized Trials in ACS and for Secondary Prevention

Presenter: Eric R. Bates, Neal S. Kleiman, Ori Ben-Yehuda

October 15, 2015

Presentation TCT 2015

Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention!

Presenter: Somjot S. Brar, Richard Solomon

October 15, 2015

Presentation TCT 2015

The Critical Role of Lesion Preparation for BRS: Effects of Plaque Morphology, Components, and Novel Devices

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Giulio Guagliumi

October 14, 2015

Presentation TCT 2015

Scaffold Expansion as the Essential Requirement to Prevent BRS Failure

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Stephan Achenbach

October 14, 2015

Presentation TCT 2015

Tips and Tricks to Optimize Acute and Long-term BRS Outcomes

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Antonio Colombo

October 14, 2015

Presentation TCT 2015

Imaging Insights Into BRS Failure Modes (Thrombosis and Restenosis)

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Yoshinobu Onuma

October 14, 2015

Presentation TCT 2015

Neoatherosclerosis After BRS May Occur

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Corrado Tamburino

October 14, 2015

Presentation TCT 2015

Incidence and Predictors of BRS Scaffold Thrombosis

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Luis Ortega Paz, MD

October 14, 2015

Presentation TCT 2015

What Are the Hard Data Regarding the Impact of Medical Therapy on Stroke Prevention in Established Severe Carotid Stenosis?

Presenter: William A. Gray, D. Christopher Metzger, Klaus D. Mathias

October 14, 2015

Advertisement

Proton-Pump Inhibitors (PPIs) Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy

Stopping vs Continuing Aspirin Before Coronary Artery Surgery

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

LAA Closure for Stroke Prevention: Rationale and Identifying the Patient Who Might Benefit

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Efficacy, Safety of Available Protocols for Aspirin Hypersensitivity for Patients Undergoing PCI

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Neurological Complications of TEVAR: Prevention and Management

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

Vorapaxar: Lessons From the Randomized Trials in ACS and for Secondary Prevention

Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention!

The Critical Role of Lesion Preparation for BRS: Effects of Plaque Morphology, Components, and Novel Devices

Scaffold Expansion as the Essential Requirement to Prevent BRS Failure

Tips and Tricks to Optimize Acute and Long-term BRS Outcomes

Imaging Insights Into BRS Failure Modes (Thrombosis and Restenosis)

Neoatherosclerosis After BRS May Occur

Incidence and Predictors of BRS Scaffold Thrombosis

What Are the Hard Data Regarding the Impact of Medical Therapy on Stroke Prevention in Established Severe Carotid Stenosis?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content